Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  BioSig Technologies Inc    BSGM

BIOSIG TECHNOLOGIES INC (BSGM)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

BioSig Technologies : Appoints New Chief Financial Officer to Facilitate Growth Trajectory

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/04/2018 | 01:14pm CET

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that Mr. Steven (Steve) Chaussy will be joining the company to serve in the role of Chief Financial Officer.

Mr. Chaussy brings over 30 years of financial and operating experience to the Company. Prior to joining BioSig Technologies, Mr. Chaussy has been the sole proprietor of Anna & Co., Inc., a consulting company that offers financial and accounting services to small publicly traded companies. Mr. Chaussy has an extensive entrepreneurial growth and development background learned from working for Penske Truck Leasing Co., L.P., a subsidiary of Penske Corporation, where his improvements of management and reporting tools have allowed the company to double in size. During his career, Mr. Chaussy also served as Chief Financial Officer to a number of private and public companies. The systems introduced by Mr. Chaussy have been key drivers of profitability and development of international business lines. Mr. Chaussy is a CPA and received his degree in Accounting from Virginia Polytechnic Institute and State University.

In his role as CFO, Mr Chaussy will be responsible for ensuring the financial organization required to support the Companys aggressive growth strategy while establishing a strong foundation for long-term progress.

"Steve has been supporting BioSig from the very beginning of our journey. As we step up our efforts towards commercialization, we needed a highly experienced, full-time CFO with the strong expertise in supporting emerging growth companies and successfully managing rapidly developing environments, stated Mr. Kenneth Londoner, Chairman & CEO of BioSig Technologies, Inc. Steves ability to navigate complex markets is a definite value-add in both our pre-commercial activities and future growth of our organization.

I am both honored and excited to be joining the BioSig team at such a key point in their trajectory, said Steven Chaussy. I am impressed with the company current assets, management team and near-term commercialization prospects. I look forward to contributing to the future success of the Company.

(c) 2018 News Central Asia (nCa). All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOSIG TECHNOLOGIES INC
01/11 BIOSIG TECHNOLOGIES : Kicks Off 2018 with Value Adds, Sets Course for Commercial..
01/09 Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations
01/08 Biosig technologies completes private placement
01/08 BIOSIG TECHNOLOGIES, INC. (OTCMKTS : BSGM) Files An 8-K Unregistered Sales of Eq..
01/05 BIOSIG TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Change in Di..
01/04 BIOSIG TECHNOLOGIES : Appoints New Chief Financial Officer to Facilitate Growth ..
01/03 BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth..
2017 BioSig Technologies to Present at Digital Medicine & Medtech Showcase at Biot..
2017 BIOSIG TECHNOLOGIES : PURE EP Aligned to Take Catheter Ablation Market by Storm ..
2017 BIOSIG TECHNOLOGIES INC : SeeThruEquity Issues Update on BioSig Technologies, In..
More news
News from SeekingAlpha
2017 ELECTROPHYSIOLOGY DEVICES : Key Players In A Fast-Growing Market
2016 How BioSig Technologies Is Positioned To Change The Electrophysiology Market
Financials ($)
Sales 2017 -
EBIT 2017 -
Net income 2017 -
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 0
Capi. / Sales 2018 205x
Capitalization 41,1 M
Chart BIOSIG TECHNOLOGIES INC
Duration : Period :
BioSig Technologies Inc Technical Analysis Chart | BSGM | US09073N1028 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 3,13 $
Spread / Average Target 116%
EPS Revisions
Managers
NameTitle
Kenneth L. Londoner Executive Chairman & Chief Executive Officer
Steven Chaussy Chief Financial Officer
Roy T. Tanaka Independent Director
Seth H. Z. Fischer Independent Director
Patrick Gallagher Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOSIG TECHNOLOGIES INC0.69%41
THERMO FISHER SCIENTIFIC12.44%85 167
DANAHER8.34%69 950
INTUITIVE SURGICAL18.71%48 542
ROYAL PHILIPS6.48%38 614
BOSTON SCIENTIFIC CORPORATION11.54%37 969